We performed RNA-sequencing of 43 breast tumor samples collected from the Rutgers Cancer Institute of New Jersey, and Oslo University Hospital20 (Radium/Rutgers) to further investigate alternative exon usage in the ER+ HER2− and ER− HER2− subgroups. The gene discussed is ESR1; the disease is breast neoplasm.